And... the Safety Cultists will dismiss this as "just another coincidence" and/or "so rare that it's worth killing or permanently disabling a few people" in the name of SAFETY!!!
Or... maybe it's not a "coincidence"... see second article re two physicians who predicted exactly this sort of reaction in certain people... and warned the FDA
https://www.jpost.com/health-science/19-year-old-hospitalized-with-heart-inflammation-after-pfizer-vaccination-65742819-year-old hospitalized in ICU days after receiving second Pfizer vaccineA 19-year-old was hospitalized with myocarditis, inflammation of the heart muscle, five days after receiving his second dose of the coronavirus vaccine, TEREM emergency medical clinics reported Monday.
According to the clinic, it has still not been confirmed that the inflammation was developed as a side effect of the vaccination. However, a number of COVID-19-related myocarditis cases have been reported, according to the US National Institutes of Health.
“The fact that the symptoms started immediately after the vaccination raises the suspicion that an immunological reaction may have caused the inflammation,” said Dr. Abdulhadi Farojeh, a TEREM medical director.
The young man received treatment at a TEREM center in Modi’in on Sunday night before being transferred for further treatment to Shamir Medical Center in Tzrifin.
He had experienced an accelerated heartbeat since the time of his second vaccine, along with shortness of breath and sharp pains that were radiating down his left arm, according to Dr. Badarnih Bahaa.
TEREM took blood tests that revealed the heart inflammation.
Without treatment, myocarditis can lead to cardiac arrhythmia and even death.
* * * * *
The "not a coincidence" evidence... read the whole article, including the one physician's letter to the FDA and Pfizer if you want the details...
https://www.lifesitenews.com/opinion/cardiothoracic-surgeon-warns-fda-pfizer-on-immunological-danger-of-covid-vaccines-in-recently-convalescent-and-asymptomatic-carriersCardiothoracic surgeon warns FDA, Pfizer on immunological danger of COVID vaccines in recently convalescent and asymptomatic carriersDr. Hooman Noorchashm says FDA, Pfizer and Moderna must consider the danger COVID vaccines pose to the recently convalescent or asymptomatic carriers of SARS-CoV-2 — especially the elderly, frail or anyone with significant cardiovascular risk factors.
January 29, 2021 (Children's Health Defense) — In a letter to the U.S. Food and Drug Administration (FDA), Pfizer and the press, Dr. Hooman Noorchashm warns of an “almost certain immunological prognotication that if viral antigens are present in the tissues of subjects who undergo vaccination, the antigen specific immune response triggered by the vaccine will target those tissues and cause tissue inflammation and damage.”
Noorchashm, M.D., Ph.D., is a physician-scientist and advocate for ethics, patient safety and women’s health. He specializes in cardiothoracic surgery and has taught and practiced medicine for nearly two decades.
“Dr. Noorchashm’s prognostications of harm in elderly individuals with cardiovascular disease coincides with the numerous reports of unexplained cardiovascular deaths following COVID-19 vaccination in Norway, Germany, the UK, Gibraltar and the U.S.,” said Lyn Redwood, RN, MSN, director and president emerita of Children’s Health Defense.
Redwood noted that J. Patrick Whelan, M.D., Ph.D., sent similar concerns to the FDA on Dec. 8, 2020.
Whelan raised even more worrisome questions, Redwood said, in that he cited research showing that in addition to the heart, ACE-2 receptors are also present in microvasculature of the brain, liver and kidney.
“Ignoring these valid and scientifically supported warnings from leading physicians may result in hundreds of millions of people suffering potentially deadly injuries or permanent damage following vaccination,” Redwood said. “It will also further erode the dwindling confidence that our country has in our federal regulatory agencies to protect the health of all Americans.”
Redwood called on the FDA and Centers for Disease Control and Prevention to convene emergency meetings to review these concerns and issue new guidelines for vaccine administration that address these concerns.